Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, KS, USA.
Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, KS, USA.
Indian Heart J. 2022 Mar-Apr;74(2):148-150. doi: 10.1016/j.ihj.2021.12.012. Epub 2022 Jan 31.
Although seen in ∼5% of sarcoidosis patients, cardiac sarcoidosis (CS) accounts for nearly 25% of disease-related deaths. This study aimed to describe characteristics and outcomes among CS patients. Patients diagnosed with CS in 2016-2017 in the US National Inpatient Sample Database were evaluated to study patient characteristics, reasons ascribed to admission, in-hospital outcomes, and complications. A total of 2420 patients (median age 56 years) were included in the analysis. Most admissions occurred due to ventricular tachycardia (12.8%), followed by myocarditis (9.9%) with a mean length of stay of 7 ± 7 days. The overall incidence of in-hospital mortality was 2.5%.
虽然在约 5%的肉样瘤病患者中可见,但心脏肉样瘤病(CS)占与疾病相关的死亡人数的近 25%。本研究旨在描述 CS 患者的特征和结局。评估了 2016-2017 年在美国国家住院患者样本数据库中诊断为 CS 的患者,以研究患者特征、入院原因、住院期间的结果和并发症。共有 2420 名患者(中位年龄 56 岁)纳入分析。大多数入院是由于室性心动过速(12.8%),其次是心肌炎(9.9%),平均住院时间为 7±7 天。住院期间总死亡率为 2.5%。